A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
A surge in violent crime and sexual offences has helped push the number of offences recorded by police past five million.
Spain will move to take full control of Catalonia after the semi-autonomous region refused to back down over its bid for independence.
A wanted man turned himself in after losing a bet he made with police on Facebook - along with promised doughnuts.